Universe Pharmaceuticals Inc (UPC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Universe Pharmaceuticals Inc (UPC) has a cash flow conversion efficiency ratio of -0.136x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.61 Million) by net assets ($56.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See UPC days of operational coverage to measure how many days the company can operate on defensive assets alone.
Universe Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Universe Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Universe Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universe Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA
|
119.987x |
|
PLAY2CHILL S.A. ZY -10
F:688
|
0.014x |
|
Yangaroo Inc
V:YOO
|
0.540x |
|
Alliance Mining Corp
V:ALM
|
0.002x |
|
BlackRock Latin American Investment Trust plc
LSE:BRLA
|
0.074x |
|
Lypsa Gems & Jewellery Limited
NSE:LYPSAGEMS
|
0.052x |
|
Lazydays Holdings Inc
NASDAQ:GORV
|
0.889x |
|
CFI-Compagnie Foncière Internationale
PA:CFI
|
0.135x |
Annual Cash Flow Conversion Efficiency for Universe Pharmaceuticals Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Universe Pharmaceuticals Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Universe Pharmaceuticals Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $56.13 Million | $-5.05 Million | -0.090x | +56.92% |
| 2024-09-30 | $45.50 Million | $-9.51 Million | -0.209x | -837.39% |
| 2023-09-30 | $39.53 Million | $1.12 Million | 0.028x | +200.27% |
| 2022-09-30 | $46.44 Million | $-1.31 Million | -0.028x | +18.99% |
| 2021-09-30 | $58.93 Million | $-2.06 Million | -0.035x | -111.87% |
| 2020-09-30 | $20.80 Million | $6.12 Million | 0.294x | -72.43% |
| 2019-09-30 | $12.38 Million | $13.20 Million | 1.066x | +131.67% |
| 2018-09-30 | $9.68 Million | $4.46 Million | 0.460x | -- |
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong … Read more